TrialPloS one2019

Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: Results of a prospective randomized multicenter study (SENATOR).

Susanne Brakemeier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.